1. Home
  2. CVRX vs CVEO Comparison

CVRX vs CVEO Comparison

Compare CVRX & CVEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVRX
  • CVEO
  • Stock Information
  • Founded
  • CVRX 2000
  • CVEO 1977
  • Country
  • CVRX United States
  • CVEO United States
  • Employees
  • CVRX N/A
  • CVEO N/A
  • Industry
  • CVRX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • CVEO Hotels/Resorts
  • Sector
  • CVRX Health Care
  • CVEO Consumer Discretionary
  • Exchange
  • CVRX Nasdaq
  • CVEO Nasdaq
  • Market Cap
  • CVRX 419.8M
  • CVEO 342.5M
  • IPO Year
  • CVRX 2021
  • CVEO N/A
  • Fundamental
  • Price
  • CVRX $13.85
  • CVEO $27.28
  • Analyst Decision
  • CVRX Strong Buy
  • CVEO Strong Buy
  • Analyst Count
  • CVRX 7
  • CVEO 1
  • Target Price
  • CVRX $17.83
  • CVEO $32.00
  • AVG Volume (30 Days)
  • CVRX 219.8K
  • CVEO 148.9K
  • Earning Date
  • CVRX 02-04-2025
  • CVEO 03-03-2025
  • Dividend Yield
  • CVRX N/A
  • CVEO 3.66%
  • EPS Growth
  • CVRX N/A
  • CVEO N/A
  • EPS
  • CVRX N/A
  • CVEO 1.44
  • Revenue
  • CVRX $51,292,000.00
  • CVEO $701,970,000.00
  • Revenue This Year
  • CVRX $27.21
  • CVEO $0.97
  • Revenue Next Year
  • CVRX $25.87
  • CVEO $3.72
  • P/E Ratio
  • CVRX N/A
  • CVEO $18.91
  • Revenue Growth
  • CVRX 30.53
  • CVEO 1.41
  • 52 Week Low
  • CVRX $6.40
  • CVEO $21.15
  • 52 Week High
  • CVRX $22.50
  • CVEO $28.92
  • Technical
  • Relative Strength Index (RSI)
  • CVRX 39.53
  • CVEO 78.14
  • Support Level
  • CVRX $14.07
  • CVEO $24.56
  • Resistance Level
  • CVRX $15.42
  • CVEO $27.55
  • Average True Range (ATR)
  • CVRX 0.88
  • CVEO 0.78
  • MACD
  • CVRX -0.23
  • CVEO 0.35
  • Stochastic Oscillator
  • CVRX 13.84
  • CVEO 94.19

About CVRX CVRx Inc.

CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.

About CVEO Civeo Corporation (Canada)

Civeo Corp provides hospitality services to the natural resources industry in Canada, Australia and the United States. The company provides a full suite of services for guests, including lodging, catering and food service, housekeeping and maintenance at accommodation facilities that the company or its customers own. The company provides services that support the day-to-day operations of these facilities, such as laundry, facility management and maintenance, water and wastewater treatments, power generation, communication systems, security and logistics. The company operates in active oil, metallurgical coal, liquefied natural gas and iron ore-producing regions. The company operates in three reportable business segments Canada, Australia and the United States.

Share on Social Networks: